Plasma metabolomic profiles associated with cardiovascular disease in type 2 diabetes from the Trans-Omics for Precision Medicine (TOPMed) program.
Saved in:
| Title: | Plasma metabolomic profiles associated with cardiovascular disease in type 2 diabetes from the Trans-Omics for Precision Medicine (TOPMed) program. |
|---|---|
| Authors: | Zhang Y; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA. Electronic address: zhangyix@bu.edu., Nguyen NQH; Human Genetics Center, Department of Epidemiology, University of Texas Health Science Center School of Public Health, Houston, TX, USA., Hanson PA; Clinical and Translational Epidemiology Unit, Mongan Institute, Massachusetts General Hospital, Boston, MA, USA., Sevilla-Gonzalez M; Clinical and Translational Epidemiology Unit, Mongan Institute, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA; Programs in Metabolism and Medical & Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Haessler J; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA., Sarnowski C; Human Genetics Center, Department of Epidemiology, University of Texas Health Science Center School of Public Health, Houston, TX, USA., Yao J; The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA., Yu B; Human Genetics Center, Department of Epidemiology, University of Texas Health Science Center School of Public Health, Houston, TX, USA., Jamshidi A; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada., Boerwinkle E; Human Genetics Center, Department of Epidemiology, University of Texas Health Science Center School of Public Health, Houston, TX, USA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA., Brown MR; Human Genetics Center, Department of Epidemiology, University of Texas Health Science Center School of Public Health, Houston, TX, USA., Chen ZZ; Division of Endocrinology and Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA., Ida Chen YD; The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA., Clish C; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., DiCorpo D; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA., Durda P; Laboratory for Clinical Biochemistry Research, Larner College of Medicine, University of Vermont, Colchester, VT, USA., Gerszten R; The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Goodarzi MO; Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Guo X; The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA., Heard-Costa NL; Framingham Heart Study, Framingham, MA, USA; Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA., Johnson WC; Department of Biostatistics, University of Washington, Seattle, WA, USA., Kooperberg C; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA., Pankow JS; Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA., Post WS; Division of Cardiology, Johns Hopkins Medicine, Baltimore, MD, USA., Reiner AP; Department of Epidemiology, University of Washington, Seattle, WA, USA., Rich SS; Department of Genome Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA., Rotter JI; The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA., de Vries PS; Human Genetics Center, Department of Epidemiology, University of Texas Health Science Center School of Public Health, Houston, TX, USA., Wood AC; USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine, Houston, TX, USA., Taylor KD; The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA., Manning AK; Clinical and Translational Epidemiology Unit, Mongan Institute, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA; Programs in Metabolism and Medical & Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Dupuis J; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada., Meigs JB; Department of Medicine, Harvard Medical School, Boston, MA, USA; Program in Population and Medical Genetics, The Broad Institute of MIT and Harvard, Cambridge, MA, USA; Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA., Liu CT; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA; Center for Health Data Science, Boston University, MA, USA. Electronic address: ctliu@bu.edu. |
| Source: | Atherosclerosis [Atherosclerosis] 2026 Jun; Vol. 417, pp. 120758. Date of Electronic Publication: 2026 Apr 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Ireland NLM ID: 0242543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1484 (Electronic) Linking ISSN: 00219150 NLM ISO Abbreviation: Atherosclerosis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
